Canakinumab works by blocking the action of IL-1beta for a period of time, inhibiting inflammation that is caused by its over-production.

Is Canakinumab approved?

In June 2020, canakinumab was approved in the United States for the indication to treat active Still’s disease, including adult-onset Still’s disease (AOSD).

How long does it take for ILARIS to work?

How fast does ILARIS work? Seven days after just 1 dose of ILARIS, the majority of patients (71%) experienced a complete response* to treatment. 97% of patients experienced improvement in their CAPS symptoms within the first treatment period (8 weeks).